Inventor
Michele A. McTigue
Inventor
Encinitas, CA, US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07KPeptides14%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%
C30BSingle-crystal growth14%
Y02ATechnologies for adaptation to climate change14%
C07DHeterocyclic compounds11%
A61KPreparations for medical, dental or toiletry purposes9%
C07CAcyclic or carbocyclic compounds6%
C07HSugars3%
PatentTitleYear
10,709,709Substituted carbonucleoside derivatives useful as anticancer agents202010,428,104Substituted nucleoside derivatives useful as anticancer agents201910,220,037Substituted carbonucleoside derivatives useful as anticancer agents20199,133,215'Macrocyclic derivatives for the treatment of diseases'20158,680,111'Macrocyclic derivatives for the treatment of diseases'20146,849,721'Modifications of the VEGF receptor-2 protein and methods of use'20056,794,146'Modifications of the VEGF receptor-2 protein and methods of use'20046,784,285'Modifications of the VEGF Receptor-2 Protein and methods of use'20046,753,416'Modifications of the VEGF receptor-2 protein and methods of use'20046,316,603'Modifications of the VEGF receptor-2 protein and methods of use'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2005Patents assigned to AGOURON PHARMA (5)· patent assignee history
2001–2020Based in Encinitas, CA, US· patent location history
2014–2020Patents assigned to PFIZER (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AGOURON PHARMA | 5 | 2001–2005 |
| PFIZER | 5 | 2014–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Encinitas, California, US | 10 | 2001–2020 |